The following is a summary of “Reliability of paramagnetic rim lesion detection at 1.5T MRI in multiple sclerosis patients,” ...

To enhance our understanding of the normal sequence of brain development in the immature ferret, we aimed to characterize postnatal neurodevelopment with conventional and diffusion MRI.

This work presents potentially important findings suggesting that a combination of transcranial stimulation approaches applied for a short period could improve memory performance after administration.

Neurodiagnostics Market Research Report In 2020, the global neurodiagnostics market was valued at $6,530 million and is projected to reach ...

Non-invasive techniques such as functional MRI (fMRI ... from their brain activity. However, this does not reveal whether such decoding of mental states, or 'brain reading' 1,2, can be practically ...

"Physician scored GU toxicity grade 2 or greater at 2 years was 51% with the CT-guided and 27% with the MRI-guided," says Amar U. Kishan, MD. In this video, Amar U. Kishan, MD, shares the initial and ...

Brain injuries are a leading cause of death and long-term disability in infants. Among the most common is neonatal hypoxic-ischemic encephalopathy (HIE), which affects one to three in 1,000 live ...

4 homozygotes (13.5%) vs heterozygotes (2.1%) or noncarriers (1.1%). Monitoring and Dose Management Guidelines Baseline brain MRI and periodic monitoring with MRI are recommended. Enhanced clinical ...

Methods In a prospective two-centre observational study, patients hospitalised with confirmed COVID-19 underwent gadolinium and manganese-enhanced MRI and CT ... 51.7±9.1 (95% CI 53.9 to 60.1) vs ...

Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...

Measurements were made by an image analyst with 2 years of experience (SS) and were approved by the board-certified neuroradiologist (NF). Statistical analyses were performed using R version 3.6.1 (R ...

The discovery and development of GLP-1 receptor agonists for type 2 diabetes and obesity is a bench-to-bedside success story.1 Multiple GLP-1 receptor agonists are now in clinical use, such as ...